GSK Investigational Site

Johnson City, New York 13790

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Asthma, Diabetes Mellitus, Type 2, Infections, Meningococcal, Influenza, Measles, Meningococcal Disease, Mumps, Respiratory Syncytial Virus Infections, Rubella, Skin Infections, Bacterial, Varicella

Studies at this site

• Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants — Completed
• Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age. — Completed
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age — Completed
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
• Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older — Completed
• A New Oral Treatment For Type II Diabetes Mellitus — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) — Completed
• Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children — Completed
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin — Completed